secwatch.observer — SEC 8-K summary
======================================

Issuer:     Certara, Inc. (CERT)
CIK:        0001827090
Form:       8-K
Filed at:   2021-10-04T23:59:59+00:00
Accession:  0001104659-21-122284
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Certara completes $310M acquisition of Pinnacle 21, a clinical data compliance SaaS provider
--------------------------------------------------------------------------------

- Enterprise value $310M; ~$250M cash + 2,239,717 restricted shares to equityholders.
- Pinnacle 21 software validates CDISC compliance required by FDA and PMDA.
- Transaction expected to be accretive to Certara's revenue, growth, and adjusted EBITDA.
- Pinnacle 21 used by FDA, PMDA, and 22 of top 25 biopharma R&D spenders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1827090/000110465921122284/0001104659-21-122284-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1827090/000110465921122284/tm2129045d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-122284

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer